Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04140734 · ClinicalTrials.gov registry record · NA
Spacer Graft Study
A NA study of Eyelid Diseases and Eyelid Droop, sponsored by Montefiore Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT04140734 is a NA study of Eyelid Diseases and Eyelid Droop that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04140734, a NA study of Eyelid Diseases and Eyelid Droop, is actively recruiting participants, sponsored by Montefiore Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine which of three types of spacer grafts (hard palate vs autologous ear cartilage vs Enduragen) are the most effective in lower eyelid retraction repair outcomes as measured by MRD2 (margin to reflex distance 2)
Conditions Studied
Interventions
- DEVICE Spacer Graft
Study Locations (1)
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2027-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04140734
The ClinicalTrials.gov registry entry for NCT04140734 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Eyelid Diseases appearing as the primary indexed condition, and to 1 intervention - of which Spacer Graft is the first listed.
NCT04140734 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04140734 about?
NCT04140734 is a clinical study titled "Spacer Graft Study". To determine which of three types of spacer grafts (hard palate vs autologous ear cartilage vs Enduragen) are the most effective in lower eyelid retraction repair outcomes as measured by MRD2 (margin to reflex distance 2)
What is the current status of trial NCT04140734?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2021-08-01. Estimated completion is 2027-07.
What conditions does trial NCT04140734 study?
This clinical trial studies the following conditions: Eyelid Diseases, Eyelid Droop.
What interventions are being tested in trial NCT04140734?
The interventions under investigation include: Spacer Graft (DEVICE).
Who is sponsoring clinical trial NCT04140734?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04140734 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eyelid Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.